People taking Ozempic and Wegovy, which contain the drug semaglutide, may be at an increased risk of developing a ...

Extensive Scientific Evidence Supporting Growth Factor Receptor Bound Protein-2 (Grb2) as Fundamental Link in Insulin ResistanceReallocates ...

With thousands of press releases published each week, it can be difficult to keep up with everything on . To help journalists ...

Previously, the STEP-HFpEF and STEP-HFpEF-DM trials were able to link semaglutide (Wegovy ... He reported other endpoints that favored tirzepatide over placebo in SUMMIT: In SUMMIT, 4.1% of ...

The top 5 most-viewed content from this year's American Society for Preventive Cardiology (ASPC) Congress on Cardiovascular ...

There have been 274 hospitalisations associated with weight-loss injections - far higher than the 68 previously detailed by ...

Many people with sleep apnea benefit from oral devices that pull the lower jaw forward and hold it there, enlarging the ...

Yesterday the NHS spending watchdog confirmed it would be rolled out to over 200,000 of the 3.4 million eligible Brits over ...

Until recently, no other drug had come close to producing the same level of weight loss as semaglutide - creating an unintended black market boom ...

GLP-1 RAs (including tirzepatide, which targets not only the ... but findings regarding this potential link have been inconsistent. In a recent review article, Drucker noted there were only ...

DealBook Summit, Lilly CEO David Ricks said GLP-1 drugs have the potential to treat more than obesity — including heart disease and substance use disorders.